Skip to content
Latest News
Nanosynth (NNN) Share Price Surged 23.4% on New Cosmetics Deal

Key points: The Nanosynth share price surged 23.4% after announcing a new joint venture. The company has partnered with a wellness firm to launch a

Simon Mugo
Joules Group’s Next Deal Maybe Borked By Share Price Fall – Why?

Key points: It's possible that Next can only buy into Joules at 33p or better The gossip is that Next isn't all that happy about this So, it's possible that the Joules d

Tim Worstall
Tim Worstall
SIMEC Atlantis (SAE) Share Price Soared 27.6% on Key Milestone

Key points: SIMEC Atlantis’ share price soared 27.6% after hitting a critical project milestone. The firm is much closer to installing the battery

Simon Mugo
NatWest Unchanged On Special Dividend – Why, Shouldn’t It Fall?

Key points: The NatWest Group share price should fall on the special dividend It hasn't, at least not for that specific reason So why has what should happen not happened?

Tim Worstall
Tim Worstall
Disney Stock Price Edges Lower Despite Reports of Record Sales

Key points: Disney stock price fell despite reports claiming it’s making record sales. The company’s move to raise the prices of its theme parks is

Simon Mugo
Amazon Stock Price Barely Moves After Closing Its Telehealth Unit

Key points: Amazon’s stock price barely moved after the tech giant closed its telehealth unit. Investors were largely unbothered by the decision an

Simon Mugo
Nasdaq Stock Price Plunged 67.6%. Why Is the Fed Not To Blame?

Key points: The Nasdaq stock plunged 67.6% on Friday, yet we can’t blame the Fed. The decline was triggered by a 3-for-1 stock split affected by th

Simon Mugo
MindMed, MNMD, Up 1,247% – Or Really, Down 11% For Meme Stock?

Key points: Mind Medicine stock was up 35% Friday Now MNMD is up another 1,247% this morning premarket Wait now, that can't be a real price rise, can it?

Tim Worstall
Tim Worstall
Athersys Down 91% YonY, Up 2,752% Today – Why’s That Really 12%?

Key points: Athersys is up 2,752% this morning premarket That's a purely nominal rise of course, not a real one The real price change is maybe 12% up, or 10% down, our c

Tim Worstall
Tim Worstall
EURUSD Price Edges Higher Ahead of the Fed Chair’s Speech

Key points: The EURUSD price edged higher ahead of Jerome Powell’s speech. Investors are waiting to gauge the future direction of Fed rate hikes.

Simon Mugo
Unilever, Burberry: 2 Inflation Resistant London Listed Stocks

Key points: With inflation still rising, what stocks should we consider Unilever benefits from its sector and potential brand loyalty Burberry's customer base is less affe

Sam Boughedda
NewAge (NBEV) Stock Rallied 17.8% Today. Should You Buy It?

Key points: NewAge (NBEV) stock rallied 17.8% despite the firm’s delisting risk. The company has not filed its 2021 and Q1 2022 financial results.

Simon Mugo
AVC Technologies (AVCT) Stock Price Surged 41.7% on New CEO

Key points: The AVC Technologies stock surged 41.7% after naming a new CEO. The cloud communications provider also appointed new directors.

Simon Mugo
Mode Global (MODE) Shares Rallied 26% on FCA Tokens Approval

Key points: Mode Global shares rallied 25.8% after FCA approved new token listings. The fintech company intends to add ten new tokens to the Mode A

Simon Mugo
Soleno Therapeutics Up 1,121% Premarket, Or Down 25% – Which Price Is Right?

Key points: We can describe Soleno Thera's stock price as being up 1,121% this morning We can also describe it as being down 25% But which is the relevant and correct des

Tim Worstall
Tim Worstall
Why Argo Blockchain (ARB) Shares Plunged 6.65% on H1 Results

Key points: Argo Blockchain shares plunged 6.65% on mixed half-year results. The miner’s revenues fell on lower Bitcoin prices as they made paper l

Simon Mugo
First Wave Biopharma 98% Down YonY, To Rise 3000% At Open – What?

Key points: First Wave Biopharma stock should rise 3,000% at open this morning This will be a purely nominal stock price move The real price move in FWBI will be the vari

Tim Worstall
Tim Worstall
Open Text Bids For Micro Focus – The Roll Up Rolled Up?

Key points: Micro Focus is up 92% on a bid offer Is there still a small margin to be had under the OpenText price offer? How much do we have to worry about political in

Tim Worstall
Tim Worstall
Oxford Cannabinoid Down 14% On Strategy Change – What Next?

Key points: Oxford Cannabinoid is cuttiung its research programme This extends the fiscal runway to allow at least one product to be fully tested But is this enough, jus

Tim Worstall
Tim Worstall
Amigo Shares Plunged by 23.4% on Weak Q1 Results. What Next?

Key points: Amigo shares plunged 23.4% after releasing its first-quarter results. Investors focused on the weak financials ignoring the tangible pr

Simon Mugo